Filter
617
Text search:
national
drug
authority
Featured
Recommendations
48
New Publications
177
Language
Document type
No document type
370
Studies & Reports
88
Guidelines
84
Manuals
28
Strategic & Response Plan
26
Training Material
8
Fact sheets
7
Situation Updates
3
Brochures
1
Resource Platforms
1
Infographics
1
Countries / Regions
Ethiopia
31
India
31
Kenya
29
South Africa
21
Uganda
20
Nigeria
17
Ghana
17
Malawi
17
Global
14
Tanzania
13
Zambia
12
Western and Central Europe
12
Cambodia
11
Zimbabwe
10
Liberia
9
Nepal
9
Philippines
8
Rwanda
8
Latin America and the Carribbean
8
Eastern Europe
8
Sierra Leone
7
Bangladesh
7
Myanmar / Burma
7
Africa
7
Namibia
6
Senegal
5
South–East Asia Region
5
Syria
4
Botswana
4
Asia
4
Afghanistan
3
Ukraine
3
Lesotho
3
Congo, Democratic Republic of
2
Cameroon
2
Pakistan
2
South Sudan
2
Papua New Guinea
2
Sudan
2
Sri Lanka
2
Middle East and North Africa
2
Palestine
2
Laos
2
Burkina Faso
1
Mali
1
Haiti
1
Somalia
1
Jordan
1
Germany
1
Lebanon
1
Turkey
1
Thailand
1
Indonesia
1
Mozambique
1
Benin
1
Central African Republic
1
Eswatini/ Swaziland
1
Hungary
1
Bolivia
1
Libya
1
Mexico
1
Yemen
1
East and Southern Africa
1
West and Central Africa
1
Western Pacific Region
1
Fiji
1
Bhutan
1
Venezuela
1
Poland
1
Albania
1
Armenia
1
Timor Leste/ East Timor
1
Tajikistan
1
Lithuania
1
Georgia
1
Vietnam
1
Gabon
1
Denmark
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
289
Clinical Guidelines
38
Public Health
30
Key Resources
27
Women & Child Health
19
Pharmacy & Technologies
15
Capacity Building
9
Toolboxes
AMR
56
HIV
48
TB
46
Mental Health
38
Pharmacy
34
COVID-19
29
Rapid Response
12
NTDs
12
Conflict
10
Planetary Health
10
Global Health Education
9
Disability
8
Refugee
8
Caregiver
8
NCDs
6
Malaria
6
Ebola & Marburg
5
Specific Hazards
5
2.0 Rapid Response
5
Cholera
4
Natural Hazards
4
Polio
2
Zika
2
Health Financing Toolbox
2
Social Ethics
1
Drug Advisory Board
The WHO Model List of Essential Medicines and Model List of Essential Medicines for Children are updated and published every two years, intended as a guide for countries or regional authorities to adopt or adapt in accordance with local priorities and treatment guidelines for the development and upd
...
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwandans.
Notable progress has also been made on other key health indicators such as reducing maternal, infant and child deaths and malnutrition, increasing immunization coverage, eliminating infectious diseases such as polio and reducing the incidence of malaria, tuberculosis and diarrhoeal diseases.
But
...
MICROBIAL DRUG RESISTANCEVolume 24, Number 5, 2018ªMary Ann Liebert, Inc.DOI: 10.1089/mdr.2017.0383
Antibiotic resistance (ABR) is a worldwide publichealth concern, with serious health, economic, and so-cietal repercussions. Its emergence is att
...
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica
...
The National Strategic Plan is based on the following guiding principles:
1) Life-course approach: adolescence is a key decade in the course of life that influences the health outcomes later in life.
2) Comprehensive approach: It recogniz ...
1) Life-course approach: adolescence is a key decade in the course of life that influences the health outcomes later in life.
2) Comprehensive approach: It recogniz ...
The Ethiopia Multi-Sectorial Cholera Elimination Plan (2022-2028) outlines a national strategy to eliminate cholera in Ethiopia by 2028. The plan follows the Global Roadmap to End Cholera by 2030 and is based on six key pillars: Leadership & Coordin
...
These standard operating procedures are intended to be used when a Member State wishes to request validation of national elimination of trachoma as a public health problem following implementation of the SAFE strategy,1 which comprises: surgery for
...
South African Health Review 2019
recommended
22nd edition
The purpose of the SAHR has always been to analyse and assess progress and challenges in key areas of the health system, and to propose recommendations for improvement. We are pleased to continue this tradition in the 2019 edition, which presents a unique collection of perspectives on
...
This publication is a companion document to the NDVP National Deployment and Vaccination Plans guidance, which provides a framework for countries to develop their national strategies. As countries
...
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this
briefing docum
...
These guidelines have been developed for scientific purpose with the main aim to guide the regulatory authority for evaluating probiotic products in our country.
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the dru
...
This working paper was conceived to offer practical tips and suggestions on how to establish and sustain the multisectoral coordination needed to develop and implement National Action Plans on AMR (NAPs). It is intended for anyone with responsibilit
...
